Abstract: A data transmission method is provided. The method is used to transmit multiple data packets, and includes the following steps. Multiple acquired data packets are mapped to different sessions according to data header information of the data packets, in which each session corresponds to one or more data packets. A data packet is encapsulated into a session message, in which the encapsulated session message includes a session identifier of the session corresponding to the one or more data packets. Multiple session messages belonging to the same session are transmitted to a next network node through at least two tunnels in link layer.

Abstract: A management method for network address translation includes: obtaining a network resource section of a client and using state information of the network resource section; adjusting the network resource section according to the using state information of the network resource section, where the adjusted network resource section can provide a network resource for all connections of the client; establishing a network address translation entry for each connection of the client according to the adjusted network resource section; and establishing a corresponding log record for the network resource section.

Abstract: A management method for network address translation includes: obtaining a network resource section of a client and using state information of the network resource section; adjusting the network resource section according to the using state information of the network resource section, where the adjusted network resource section can provide a network resource for all connections of the client; establishing a network address translation entry for each connection of the client according to the adjusted network resource section; and establishing a corresponding log record for the network resource section.

Abstract: Uteroglobin has been discovered to prevent IgA mediated diseases, such as IgA nephropathy, by preventing the deposition of IgA-Fibronectin immunocomplexes in tissues such as the renal glomeruli. The invention therefore includes methods of treating such diseases by administering therapeutically effective amounts of uteroglobin (and variants or mimetics) to prevent or improve the IgA mediated condition. Transgenic uteroglobin knockout animals, and animals in which uteroglobin-protein expression is reduced by antisense technology, also provide systems for studying IgA mediated diseases, and screening for appropriate treatments.

Abstract: A data transmission method is provided. The method is used to transmit multiple data packets, and includes the following steps. Multiple acquired data packets are mapped to different sessions according to data header information of the data packets, in which each session corresponds to one or more data packets. A data packet is encapsulated into a session message, in which the encapsulated session message includes a session identifier of the session corresponding to the one or more data packets. Multiple session messages belonging to the same session are transmitted to a next network node through at least two tunnels in link layer.

Abstract: Uteroglobin has been discovered to prevent IgA mediated diseases, such as IgA nephropathy, by preventing the deposition of IgA-Fibronectin immunocomplexes in tissues such as the renal glomeruli. The invention therefore includes methods of treating such diseases by administering therapeutically effective amounts of uteroglobin (and variants or mimetics) to prevent or improve the IgA mediated condition. Transgenic uteroglobin knockout animals, and animals in which uteroglobin-protein expression is reduced by antisense technology, also provide systems for studying IgA mediated diseases, and screening for appropriate treatments.

Abstract: Method for treatment of inflammatory and fibrotic conditions in vivo using pure rhUG is disclosed. Method for treating or preventing inflammatory or fibrotic conditions characterized by a deficiency of endogenous functional UG is also disclosed. Compositions containing pure rhUG, optionally also containing lung surfactant, and assay procedures for detection of UG-fibronectin complexes, are also provided.

Abstract: Methods for treatment of inflammatory and fibrotic conditions in vivo using UG is disclosed. Methods for treating or preventing inflammatory or fibrotic conditions characterized by a deficiency of endogenous functional UG are also disclosed. Compositions containing UG, optionally containing lung surfactant, and assay procedures for detection of UG-fibronectin complexes, are also provided.

Abstract: Method for treatment of inflammatory and fibrotic conditions in vivo using pure rhUG is disclosed. Method for treating or preventing inflammatory or fibrotic conditions characterized by a deficiency of endogenous fictional UG is also disclosed. Compositions containing pure rhUG, optionally also containing lung surfactant, and assay procedures for detection of UG-fibronectin complexes, are also provided.

Abstract: Compositions and methods for preventing or treating primary cancer cell growth and tumor metastasis, as well as stimulation of hematopoiesis are described and claimed. The present invention also relates to methods of treating cancer and uteroglobin receptor-related conditions by targeting a uteroglobin receptor with recombinant human uteroglobin (rhUG). Also disclosed and claimed are methods of purifying a uteroglobin receptor and methods of using such receptor(s) to identify uteroglobin structural analogs and UG-receptor ligands.

Abstract: Method for treatment of inflammatory and fibrotic conditions in vivo using pure rhUG is disclosed. Method for treating or preventing inflammatory or fibrotic conditions characterized by a deficiency of endogenous functional UG is also disclosed. Compositions containing pure rhUG, optionally also containing lung surfactant, and assay procedures for detection of UG-fibronectin complexes, are also provided.